Simeon Grazio
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Simeon Grazio has a total of 263 co-authors. Here are the top co-authors by number of shared publications:
Branimir Anić
11 shared publications- Frane Grubisić
Department of Rheumatology, Physical Medicine and Rehabilitation,University Hospital Center Sisters of Mercy, Vinogradska 29, 10 000 Zagreb and Croatia, --- Select a Country --
11 shared publications - Tonko Vlak
Division of Physical and Rehabilitation Medicine with Rheumatology, University Hospital Center Split, Split, Croatia
11 shared publications - Jadranka Morović-Vergles
Division of Clinical Immunology, Allergology and Rheumatology, Department of Internal Medicine Dubrava University Hospital Zagreb Croatia
10 shared publications - Durdica Babić-Naglić9 shared publications
- Frane Grubišić
Department of Rheumatology, Physical and Rehabilitation Medicine, Sestre milosrdnice University Hospital Center, 10000 Zagreb, Croatia
9 shared publications
Latest Publications
- Open Access
- 1 January 2027
- Published by XMLink in Journal of Korean Medical Science
- Vol. 42
Healthcare Professionals’ Knowledge, Attitudes, and Views on Local and Regional Academic Journals And Their Development Perspectives
Aldiyar A, et al. J Korean Med Sci. 2027 Mar;42:e40. https://doi.org/10.3346/jkms.2027.42.e40
- 1 January 2027
- Published by XMLink in Journal of Korean Medical Science
- Vol. 42
Open AccessHealthcare Professionals’ Knowledge, Attitudes, and Views on Local and Regional Academic Journals And Their Development Perspectives
Aldiyar A, et al. J Korean Med Sci. 2027 Mar;42:e40. https://doi.org/10.3346/jkms.2027.42.e40
- 12 November 2026
- Published by Croatian Medical Association in Lijecnicki Vjesnik
- p. 263
Conservative treatment of patients with low-back pain: Guidelines of the Croatian Society of Vertebrology
Objective: To develop updated national guidelines for the conservative treatment of adults with low back pain, as a continuation of the previously published Croatian Society of Vertebrology guidelines on classification, diagnostic work-up, and outcome measures. Methods: A systematic literature review was conducted according to the previously published methodology of the Croatian Society of Vertebrology. A multidisciplinary panel reviewed the available evidence and formulated recommendations through discussion, voting, and consensus using a predefined GRADE framework. Recommendation strength reflects panel consensus reached through the predefined process and is not synonymous with the quality or certainty of the evidence. When the available evidence was insufficient to reliably guide a clinical decision, no recommendation was formulated. Results: A total of 67 recommendations were formulated, including 16 strong and 51 conditional recommendations. Education, maintenance of activity, and self-management are the foundations of conservative care, while complete bed rest should be avoided. In acute low back pain, pharmacological treatment should be short term and individualized, with non-steroidal anti-inflammatory drugs recommended after assessment of benefits and risks. Routine early prescription of a structured exercise programme is not recommended for acute non-specific low back pain; however, patients should be strongly encouraged to remain active. Individualized structured exercise is recommended in subacute low back pain, while exercise therapy is a cornerstone of chronic low back pain management, with the programme selected according to the patient’s needs, abilities, and preferences. Psychological interventions and multidisciplinary biopsychosocial programmes should be used selectively, particularly in patients with psychosocial barriers to recovery, substantial disability, or an inadequate response to first-line care. Passive physical and manual therapies, when used, should complement rather than replace an active treatment programme. Routine use of several interventions is discouraged because of insufficient or unfavourable evidence. Conclusion: These guidelines support an individualized, active, and biopsychosocially oriented approach to conservative low back pain management. Priority should be given to education, maintenance of activity, exercise therapy in the subacute and chronic stages, and targeted psychological and multidisciplinary interventions in selected patients, while pharmacological and passive treatments should be used rationally and selectively according to their expected benefits and risks.
- 12 November 2026
- Published by Croatian Medical Association in Lijecnicki Vjesnik
- p. 263
Conservative treatment of patients with low-back pain: Guidelines of the Croatian Society of Vertebrology
Objective: To develop updated national guidelines for the conservative treatment of adults with low back pain, as a continuation of the previously published Croatian Society of Vertebrology guidelines on classification, diagnostic work-up, and outcome measures. Methods: A systematic literature review was conducted according to the previously published methodology of the Croatian Society of Vertebrology. A multidisciplinary panel reviewed the available evidence and formulated recommendations through discussion, voting, and consensus using a predefined GRADE framework. Recommendation strength reflects panel consensus reached through the predefined process and is not synonymous with the quality or certainty of the evidence. When the available evidence was insufficient to reliably guide a clinical decision, no recommendation was formulated. Results: A total of 67 recommendations were formulated, including 16 strong and 51 conditional recommendations. Education, maintenance of activity, and self-management are the foundations of conservative care, while complete bed rest should be avoided. In acute low back pain, pharmacological treatment should be short term and individualized, with non-steroidal anti-inflammatory drugs recommended after assessment of benefits and risks. Routine early prescription of a structured exercise programme is not recommended for acute non-specific low back pain; however, patients should be strongly encouraged to remain active. Individualized structured exercise is recommended in subacute low back pain, while exercise therapy is a cornerstone of chronic low back pain management, with the programme selected according to the patient’s needs, abilities, and preferences. Psychological interventions and multidisciplinary biopsychosocial programmes should be used selectively, particularly in patients with psychosocial barriers to recovery, substantial disability, or an inadequate response to first-line care. Passive physical and manual therapies, when used, should complement rather than replace an active treatment programme. Routine use of several interventions is discouraged because of insufficient or unfavourable evidence. Conclusion: These guidelines support an individualized, active, and biopsychosocially oriented approach to conservative low back pain management. Priority should be given to education, maintenance of activity, exercise therapy in the subacute and chronic stages, and targeted psychological and multidisciplinary interventions in selected patients, while pharmacological and passive treatments should be used rationally and selectively according to their expected benefits and risks.
- Open Access
- 4 November 2025
- Published by Croatian Medical Association in Reumatizam
- Vol. 72 (Supp 1) , 36
ASAS class ification criteria for axial spondyloarthritis 2025
- 4 November 2025
- Published by Croatian Medical Association in Reumatizam
- Vol. 72 (Supp 1) , 36
Open AccessASAS class ification criteria for axial spondyloarthritis 2025
- 18 September 2025
- Published by Croatian Medical Association in Fizikalna i rehabilitacijska medicina
THE EFFECTS OF TECAR THERAPY ON PAIN, DISEASE ACTIVITY, RANGE OF MOTION AND FUNCTION IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS
Background and Aims The Transfer of Energy Capacitive and Resistive (TECAR) therapy is PRM modality that predominantly increases tissue temperature, promotes blood flow and improves oxygen and nutrient delivery while reducing swelling and pain. TECAR therapy is used for numerous indications, including low back pain, knee osteoarthritis, painful shoulder, myofascial pain syndrome and many others. The aim of this study was to evaluate the effect of TECAR, on pain intensity (VAS), disease activity (VAS-GDA and Bath Ankylosing Spondylitis Disease Activity Index-BASDAI), function (Bath Ankylosing Spondylitis Functional Index-BASFI), and the range of motion (Bath Ankylosing Spondylitis Metrology Index-BASMI), in individuals with axial spondyloarthritis (axSpA), immediately after stopping the therapy (T1) and one month thereafter (T2). Methods TECAR was applied in 6 sessions during 2 or 3 weeks, alongside exercise for patients with axSpA. Results The study included 33 individuals of both sexes, aged between 18 and 65 years. In comparison with baseline values in T1 visit there was an improvement in VAS-pain (median baseline 6 vs 3; the average decrease of 44.82%), VAS-GDA (the median 5 vs 3; the average decrease of 26.88%). Also, BASDAI decreased by an average of 34.58%, BASMI by 28.27%, and BASFI by 27.47%. When comparing the results of 20 patients between T0 and T2 the positive effects faded away for BASDAI (-5.47%), but partially persisted for VAS-GDA (28.6%), BASFI (16.78%) and VAS-pain (17.2%). Conclusion In our study of patients with axSpA, TECAR therapy has proven to be successful in alleviating pain, decreasing inflammation, and improving range of motion and function. Also, data showed that the effect for the majority of observed outcomes might not be long-lasting. Future research is needed to determine the extent to which TECAR therapy can reduce analgesic use and to compare its effect with some other treatment modalities.
- 18 September 2025
- Published by Croatian Medical Association in Fizikalna i rehabilitacijska medicina
THE EFFECTS OF TECAR THERAPY ON PAIN, DISEASE ACTIVITY, RANGE OF MOTION AND FUNCTION IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS
Background and Aims The Transfer of Energy Capacitive and Resistive (TECAR) therapy is PRM modality that predominantly increases tissue temperature, promotes blood flow and improves oxygen and nutrient delivery while reducing swelling and pain. TECAR therapy is used for numerous indications, including low back pain, knee osteoarthritis, painful shoulder, myofascial pain syndrome and many others. The aim of this study was to evaluate the effect of TECAR, on pain intensity (VAS), disease activity (VAS-GDA and Bath Ankylosing Spondylitis Disease Activity Index-BASDAI), function (Bath Ankylosing Spondylitis Functional Index-BASFI), and the range of motion (Bath Ankylosing Spondylitis Metrology Index-BASMI), in individuals with axial spondyloarthritis (axSpA), immediately after stopping the therapy (T1) and one month thereafter (T2). Methods TECAR was applied in 6 sessions during 2 or 3 weeks, alongside exercise for patients with axSpA. Results The study included 33 individuals of both sexes, aged between 18 and 65 years. In comparison with baseline values in T1 visit there was an improvement in VAS-pain (median baseline 6 vs 3; the average decrease of 44.82%), VAS-GDA (the median 5 vs 3; the average decrease of 26.88%). Also, BASDAI decreased by an average of 34.58%, BASMI by 28.27%, and BASFI by 27.47%. When comparing the results of 20 patients between T0 and T2 the positive effects faded away for BASDAI (-5.47%), but partially persisted for VAS-GDA (28.6%), BASFI (16.78%) and VAS-pain (17.2%). Conclusion In our study of patients with axSpA, TECAR therapy has proven to be successful in alleviating pain, decreasing inflammation, and improving range of motion and function. Also, data showed that the effect for the majority of observed outcomes might not be long-lasting. Future research is needed to determine the extent to which TECAR therapy can reduce analgesic use and to compare its effect with some other treatment modalities.
- Open Access
- 18 September 2025
- Published by Croatian Medical Association in Fizikalna i rehabilitacijska medicina
- Vol. 39 (3-4) , 175-176
DIAGNOSTIC CHALLENGES IN INFLAMMATORY BACK PAIN /AXIAL SPONDYLOARTHRITIS
- 18 September 2025
- Published by Croatian Medical Association in Fizikalna i rehabilitacijska medicina
- Vol. 39 (3-4) , 175-176
Open AccessDIAGNOSTIC CHALLENGES IN INFLAMMATORY BACK PAIN /AXIAL SPONDYLOARTHRITIS
- 4 September 2025
- Published by Springer Nature in Clinical Rheumatology
- Vol. 44 (10) , 4033-4041
The relationship between vitamin D receptor (VDR) genomic polymorphisms, disease activity, and functional ability in patients with psoriatic arthritis
Introduction/objectives Psoriatic arthritis (PsA) is a chronic inflammatory rheumatic disease strongly associated with psoriasis. We hypothesized that the presence of variant alleles in VDR may be associated with worse clinical outcomes. The aim of this study was to evaluate a possible association between the FokI and TaqI polymorphisms in the VDR gene and clinical markers of disease activity and functional status in PsA. Method Study included 68 patients with PsA. Diagnosis was confirmed according to fulfillment of CASPAR criteria for PsA. Disease activity for peripheral arthritis was evaluated using the DAPSA index; global assessment of disease activity and pain were assessed using VAS. BASDAI was used for the axial form of PsA. Functional ability was assessed by HAQ-DI and FACIT-F. BASFI was used for measuring the functional status of axial involvement. Overall functional mobility was assessed with TUG. Laboratory tests included genotyping of the FokI (rs2228570) and TaqI (rs731236), as well as CRP, ESR, IL-6, and 25(OH)D3. Significance was set at P < 0.05. Results Significant difference in FokI polymorphism was observed for intensity of pain, with the T/T genotype reporting worse outcomes than C/C (P = 0.049). BASDAI showed significant differences (P = 0.026), with T/T genotype having higher values than C/C genotype. Conclusions FokI polymorphism may have a potential role in modulating disease activity and pain perception in patients with PsA, whereas the TaqI polymorphism appears to have less impact on clinical outcomes. The findings emphasize the need for further research to better understand the genetic impact on disease severity in PsA. Key Points • Study suggests that the FokI polymorphism may have a potential role in modulating disease activity and pain perception in patients with inflammatory diseases, such as PsA. • TaqI polymorphism appears to have less impact on clinical outcomes in PsA. • This is a rare study where an association between the polymorphisms in the VDR gene with PsA and its clinical forms and biochemical parameters was investigated.
- 4 September 2025
- Published by Springer Nature in Clinical Rheumatology
- Vol. 44 (10) , 4033-4041
The relationship between vitamin D receptor (VDR) genomic polymorphisms, disease activity, and functional ability in patients with psoriatic arthritis
Introduction/objectives Psoriatic arthritis (PsA) is a chronic inflammatory rheumatic disease strongly associated with psoriasis. We hypothesized that the presence of variant alleles in VDR may be associated with worse clinical outcomes. The aim of this study was to evaluate a possible association between the FokI and TaqI polymorphisms in the VDR gene and clinical markers of disease activity and functional status in PsA. Method Study included 68 patients with PsA. Diagnosis was confirmed according to fulfillment of CASPAR criteria for PsA. Disease activity for peripheral arthritis was evaluated using the DAPSA index; global assessment of disease activity and pain were assessed using VAS. BASDAI was used for the axial form of PsA. Functional ability was assessed by HAQ-DI and FACIT-F. BASFI was used for measuring the functional status of axial involvement. Overall functional mobility was assessed with TUG. Laboratory tests included genotyping of the FokI (rs2228570) and TaqI (rs731236), as well as CRP, ESR, IL-6, and 25(OH)D3. Significance was set at P < 0.05. Results Significant difference in FokI polymorphism was observed for intensity of pain, with the T/T genotype reporting worse outcomes than C/C (P = 0.049). BASDAI showed significant differences (P = 0.026), with T/T genotype having higher values than C/C genotype. Conclusions FokI polymorphism may have a potential role in modulating disease activity and pain perception in patients with PsA, whereas the TaqI polymorphism appears to have less impact on clinical outcomes. The findings emphasize the need for further research to better understand the genetic impact on disease severity in PsA. Key Points • Study suggests that the FokI polymorphism may have a potential role in modulating disease activity and pain perception in patients with inflammatory diseases, such as PsA. • TaqI polymorphism appears to have less impact on clinical outcomes in PsA. • This is a rare study where an association between the polymorphisms in the VDR gene with PsA and its clinical forms and biochemical parameters was investigated.
- Open Access
- 17 March 2025
- Published by Opca bolnica Zadar in Medica Jadertina
- Vol. 55 (1) , 31-42
Utjecaj pretilosti na etiopatogenezu, tijek bolesti i liječenje spondiloartritisa
Spondiloartritisi predstavljaju heterogenu grupu upalnih reumatskih bolesti koje zahvaćaju aksijalni skelet i/ili periferne zglobove i okolne strukture s mogućim izvanzglobnim manifestacijama. Cilj ovoga preglednog rada je evaluirati utjecaj pretilosti na etiopatogenezu, aktivnost bolesti i liječenje spondiloartritisa temeljeno na sistematskom pregledu literature. Pretilost negativno utječe na simptome, funkcionalnu sposobnost, ukupni teret bolesti, te mijenja farmakokinetiku određenih lijekova. TNFα-inhibitori pokazuju smanjenu učinkovitost kod pretilih bolesnika, te mogu dovesti do povećanja tjelesne mase i stvaranja abdominalnog tkiva. IL-12/23 inhibitori, poput ustekinumaba pokazuju manji učinak na povećanje tjelesne mase. Istraživanja o IL-17 i IL-23 inhibitorima, uključujući guselkumab, sugeriraju da pretilost nema značajan učinak na njihovu učinkovitost, dok su rezultati za IL-23 inhibitor, risankizumab proturječni. Primjena PDE4 inhibitora apremilasta povezuje se s gubitkom tjelesne mase i smanjenjem HbA1c vrijednosti, što ga čini pogodnim za bolesnike s metaboličkim sindromom. Za JAK-inhibitore, učinkovitost je uglavnom neovisna o tjelesnoj masi, iako je za tofacitinib primijećena smanjena učinkovitost kod bolesnika s indeksom tjelesne mase ≥35 kg/m², dok za upadacitinib ne postoje dostupne kliničke studije koje evaluiraju utjecaj pretilosti na terapijski učinak. Zaključno, u bolesnika sa spondiloartritisima pretilost je ključan čimbenik u etiopatogenezi i teretu bolesti, a za neke lijekove/grupe lijekova važna je pri odabiru terapijskih opcija.
- 17 March 2025
- Published by Opca bolnica Zadar in Medica Jadertina
- Vol. 55 (1) , 31-42
Open AccessUtjecaj pretilosti na etiopatogenezu, tijek bolesti i liječenje spondiloartritisa
Spondiloartritisi predstavljaju heterogenu grupu upalnih reumatskih bolesti koje zahvaćaju aksijalni skelet i/ili periferne zglobove i okolne strukture s mogućim izvanzglobnim manifestacijama. Cilj ovoga preglednog rada je evaluirati utjecaj pretilosti na etiopatogenezu, aktivnost bolesti i liječenje spondiloartritisa temeljeno na sistematskom pregledu literature. Pretilost negativno utječe na simptome, funkcionalnu sposobnost, ukupni teret bolesti, te mijenja farmakokinetiku određenih lijekova. TNFα-inhibitori pokazuju smanjenu učinkovitost kod pretilih bolesnika, te mogu dovesti do povećanja tjelesne mase i stvaranja abdominalnog tkiva. IL-12/23 inhibitori, poput ustekinumaba pokazuju manji učinak na povećanje tjelesne mase. Istraživanja o IL-17 i IL-23 inhibitorima, uključujući guselkumab, sugeriraju da pretilost nema značajan učinak na njihovu učinkovitost, dok su rezultati za IL-23 inhibitor, risankizumab proturječni. Primjena PDE4 inhibitora apremilasta povezuje se s gubitkom tjelesne mase i smanjenjem HbA1c vrijednosti, što ga čini pogodnim za bolesnike s metaboličkim sindromom. Za JAK-inhibitore, učinkovitost je uglavnom neovisna o tjelesnoj masi, iako je za tofacitinib primijećena smanjena učinkovitost kod bolesnika s indeksom tjelesne mase ≥35 kg/m², dok za upadacitinib ne postoje dostupne kliničke studije koje evaluiraju utjecaj pretilosti na terapijski učinak. Zaključno, u bolesnika sa spondiloartritisima pretilost je ključan čimbenik u etiopatogenezi i teretu bolesti, a za neke lijekove/grupe lijekova važna je pri odabiru terapijskih opcija.
- Open Access
Optomechanical Analysis of Gait in Patients with Ankylosing Spondylitis
Ankylosing spondylitis (AS) is a chronic inflammatory rheumatic disease associated with alterations in posture and gait. The aim of this study was to assess the gait of AS patients using pedobarography and a markerless motion capture system. This is the first study of this population to combine these two methods. Twelve AS patients and twelve healthy controls were enrolled in this study. An instrumented gait analysis of both groups was performed using pedobarography and Microsoft Kinect v2. The AS group was significantly older than the controls (p < 0.05). The AS group showed a significantly lower relative pressure distribution in the front-right quadrant (p = 0.01) and a significantly higher relative pressure distribution in the rear-right quadrant (p = 0.05) on the static pedobarography. The AS group also had a higher peak force in the midfoot on the dynamic pedobarography (p < 0.05). The AS group had a significantly shorter stride length (p = 0.01). No significant differences between the groups were found in their hip flexion/extension and adduction/abduction, knee flexion, or ankle dorsiflexion/plantarflexion angles. This study shows significant alterations in the pedobarographic and spatiotemporal, but not in the kinematic, gait parameters of AS patients. These alterations represent a feature of AS and not antalgic adjustments. Rehabilitation programs for AS patients could be tailored according to the results of an instrumented gait analysis and should include balance and gait exercises.
Open AccessOptomechanical Analysis of Gait in Patients with Ankylosing Spondylitis
Ankylosing spondylitis (AS) is a chronic inflammatory rheumatic disease associated with alterations in posture and gait. The aim of this study was to assess the gait of AS patients using pedobarography and a markerless motion capture system. This is the first study of this population to combine these two methods. Twelve AS patients and twelve healthy controls were enrolled in this study. An instrumented gait analysis of both groups was performed using pedobarography and Microsoft Kinect v2. The AS group was significantly older than the controls (p < 0.05). The AS group showed a significantly lower relative pressure distribution in the front-right quadrant (p = 0.01) and a significantly higher relative pressure distribution in the rear-right quadrant (p = 0.05) on the static pedobarography. The AS group also had a higher peak force in the midfoot on the dynamic pedobarography (p < 0.05). The AS group had a significantly shorter stride length (p = 0.01). No significant differences between the groups were found in their hip flexion/extension and adduction/abduction, knee flexion, or ankle dorsiflexion/plantarflexion angles. This study shows significant alterations in the pedobarographic and spatiotemporal, but not in the kinematic, gait parameters of AS patients. These alterations represent a feature of AS and not antalgic adjustments. Rehabilitation programs for AS patients could be tailored according to the results of an instrumented gait analysis and should include balance and gait exercises.
- Top Cited PapersOpen Access
- 14 February 2025
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 84 (4) , 538-546
The Assessment of SpondyloArthritis International Society (ASAS) Consensus-Based Expert Definition of Difficult-to-Manage, including Treatment-Refractory, Axial Spondyloarthritis
- 14 February 2025
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 84 (4) , 538-546
Top Cited PapersOpen AccessThe Assessment of SpondyloArthritis International Society (ASAS) Consensus-Based Expert Definition of Difficult-to-Manage, including Treatment-Refractory, Axial Spondyloarthritis
- Open Access
- 17 January 2025
- Published by Springer Nature in Rheumatology International
- Vol. 45 (2) , 1
Correction: Physical component of SF-36 is associated with measures of disease activity in patients with psoriatic arthritis: a real-life study from a tertiary referral centre
- 17 January 2025
- Published by Springer Nature in Rheumatology International
- Vol. 45 (2) , 1
Open AccessCorrection: Physical component of SF-36 is associated with measures of disease activity in patients with psoriatic arthritis: a real-life study from a tertiary referral centre